Application 208749
- Type
- ANDA
- Sponsor
- MAIA PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 100MCG/VIAL | No | No |
| 002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 200MCG/VIAL | No | No |
| 003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 500MCG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208749-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | |
| A208749-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | |
| A208749-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208749-001 | AP |
| A208749-002 | AP |
| A208749-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208749-002 | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208749-003 | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208749-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2018-12-21 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208749-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208749-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208749-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208749-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208749-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208749-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208749-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208749-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208749-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208749-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208749-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208749-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208749-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208749-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208749-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208749-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208749-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208749-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208749-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208749-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208749-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208749-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208749-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208749-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208749-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208749-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208749-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A208749-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A208749-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A208749-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208749-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208749-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208749-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208749-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208749-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208749-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208749-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208749-002 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208749-003 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A208749-001 | AP | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Sagent Pharmaceuticals | f57e9b19-6f17-4520-80fc-511322cc56c9 | 2023-10-19 | Boxed warning, Warnings, Adverse reactions | 208749 ANDA208749 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | MAIA Pharmaceuticals, Inc. | 4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd | 2019-01-30 | Boxed warning, Warnings, Adverse reactions | 208749 ANDA208749 70511-112 70511-113 70511-111 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70511-111 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | MAIA Pharmaceuticals, Inc. | ANDA | Current |
| 70511-112 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | MAIA Pharmaceuticals, Inc. | ANDA | Current |
| 70511-113 | Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | MAIA Pharmaceuticals, Inc. | ANDA | Current |
| 70860-451 | Levothyroxine Sodium | levothyroxine sodium anhydrous | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 70860-452 | Levothyroxine Sodium | levothyroxine sodium anhydrous | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 70860-453 | Levothyroxine Sodium | levothyroxine sodium anhydrous | Athenex Pharmaceutical Division, LLC. | ANDA | Current |